Presentation Information
[3F-08]Company Introduction
*Akihito Sawada1, Yusuke Okada1, Takeru Yamakawa1 (1. Infectious Disease Control Labs, Group 1 Drug Discovery Department Meiji Seika Pharma Co., Ltd. (Japan))
Keywords:
Infection disease,Vaccine,Covid-19
Comment
To browse or post comments, you must log in.Log in